Codexis (CDXS) Interest & Investment Income (2010 - 2026)
Codexis' (CDXS) quarterly Interest & Investment Income came in at $665000.0 in Q1 2026, down 11.45% year-on-year from $751000.0 in Q1 2025, and up 1.37% quarter-over-quarter from $656000.0 in Q4 2025.
Codexis (CDXS) Interest & Investment Income (2010 - 2026) Analysis & Trends
Codexis' Interest & Investment Income history runs 17 years deep, the most recent figure standing at $665000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 11.45% year-over-year to $665000.0 in Q1 2026; TTM through Mar 2026 was $2.5 million, a 27.71% decrease from a year earlier, with the FY2025 full-year figure at $2.6 million, down 28.47% from the prior year.
- Interest & Investment Income advanced to $665000.0 in Q1 2026 per CDXS's latest filing, from $656000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.1 million in Q2 2023 and bottomed at $42000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $823000.0 (2022), against an average of $739588.2.
- Across the five-year window, Interest & Investment Income plunged 76.27% in 2022 and surged 2492.86% in 2023, its largest moves.
- Year by year, Interest & Investment Income stood at $823000.0 in 2022, then gained by 10.09% to $906000.0 in 2023, then climbed by 3.75% to $940000.0 in 2024, then tumbled by 30.21% to $656000.0 in 2025, then advanced by 1.37% to $665000.0 in 2026.
- Per Business Quant, the three latest CDXS Interest & Investment Income figures stand at $665000.0 (Q1 2026), $656000.0 (Q4 2025), and $634000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Codexis | 135.70 Mn | 70.56 Mn | 13.18 Mn | 665,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 665,000.00 |
| Dec 31, 2025 | 656,000.00 |
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | 584,000.00 |
| Mar 31, 2025 | 751,000.00 |
| Dec 31, 2024 | 940,000.00 |
| Sep 30, 2024 | 849,000.00 |
| Jun 30, 2024 | 972,000.00 |
| Mar 31, 2024 | 909,000.00 |
| Dec 31, 2023 | 906,000.00 |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 1.09 Mn |
| Dec 31, 2022 | 823,000.00 |
| Sep 30, 2022 | 436,000.00 |
| Jun 30, 2022 | 140,000.00 |
| Mar 31, 2022 | 42,000.00 |
| Dec 31, 2021 | 35,000.00 |
| Sep 30, 2021 | 41,000.00 |
| Jun 30, 2021 | 206,000.00 |